Preoperative carboplatin and paclitaxel-based chemoradiotherapy
07/09/15 Portland, Ore.
Worldwide, esophageal cancer is the sixth leading cause of cancer-related mortality. In the USA, adenocarcinoma histological subtype is most common because of higher rates of obesity and gastroesophageal reflux disease.
Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma